Management of Optic Neuritis

Experts in the field of optic neuritis management discuss the initial diagnostic process of optic neuritis.

A discussion on best practices of patients with optic neuritis who present with brain lesions and a pivotal MRI trial and its impact on the treatment paradigm.

Key opinion leaders provide an overview of the treatment landscape for optic neuritis and multiple sclerosis.

A discussion on the prevalence, management, and treatment of myelin oligodendrocyte glycoprotein (MOG) optic neuritis and neuromyelitis optica (NMO).

Key opinion leaders discuss the importance of the high-contrast visual acuity tests to monitor for cognitive impairment in patients with optic neuritis subtypes. 

A discussion on a small trial using adrenocorticotropic hormones (ACTH) to treat acute optic neuritis and improve vision.

Key opinion leaders discuss how to circumnavigate COVID-19–related difficulties and effectively, reliably and safely treat patients with optic neuritis and multiple sclerosis.

Experts in the field of optic neuritis management provide a take-home message for community physicians who treat and manage patients with optic neuritis, multiple sclerosis, and disease subtypes. 
SAP Partner Banner